ArticleNeoplasia (New York, N.Y.)2009

Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations.

Ludovica Ciuffreda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.